Calcium entry blocking activities of MPC-1304 and of its enantiomers and metabolites

This publication has 11 references indexed in Scilit:

• Antihypertensive Effects of MPC-1304, a Novel Calcium Antagonist, in Experimental Hypertensive Rats and Dogs
  Journal of Cardiovascular Pharmacology, 1992
• Pharmacodynamic and pharmacological effects of MPC-1304, a new calcium channel blocker, in healthy subjects. Results of single oral administration.
  Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1990
• 1,4-Dihydropyridine activators and antagonists: structural and functional distinctions
  Trends in Pharmacological Sciences, 1989
• Gas chromatographic-negative-ion chemical ionization mass spectrometric determination of a new dihydropyridine calcium antagonist (MPC-1304) and its metabolites in human plasma and urine
  Journal of Chromatography B: Biomedical Sciences and Applications, 1988
• Synthesis of asymmetric 4-aryl-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylates with vasodilating and antihypertensive activities.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
• The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels
  European Journal of Pharmacology, 1985
• Stereoselectivity at the Calcium Channel
  Journal of Cardiovascular Pharmacology, 1985
• Vasodilator and hypotensive effects of the optical isomers of nicardipine (YC-93),a new Ca2+-antagonist.
  The Japanese Journal of Pharmacology, 1982
• Effects of unsymmetrical ester substituted 1,4-dihydropyridine derivatives and their optical isomers on contraction of smooth muscle
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1981
• Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1975